Jin Hui Paik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jin Hui Paik has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Dae Young Hong
Department of Emergency Medicine, Konkuk University School of Medicine, Seoul, Korea
3 shared publications - Hee Young Lee
Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Gangwon State, Republic of Korea
3 shared publications - Hyun Kim
Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea
3 shared publications - Hyun Min Jung
Department of Emergency Medicine, Inha University School of Medicine, Incheon, Korea
3 shared publications Soo Kang
Department of Emergency medicine Inha University College of Medicine Jung-Gu 22232 Incheon Republic of Korea
3 shared publications- Soo Kang
Department of Emergency Medicine, Inha University College of Medicine, Incheon, Korea
3 shared publications
Latest Publications
- Open Access
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45442
Serum amyloid A as a prognostic biomarker for 30-day mortality in patients with community-acquired pneumonia patients in the emergency department
Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality, particularly in older adults. Accurate risk assessment of patients with CAP in the emergency department (ED) is essential for guiding clinical decision-making. This study evaluated the prognostic value of serum amyloid A (SAA) levels for predicting 30-day mortality in patients with CAP presenting to the ED. The data of 398 adult patients with CAP who were admitted to the ED between November 2022 and March 2025 were retrospectively analyzed. Clinical parameters, laboratory biomarkers, and Pneumonia Severity Index (PSI) score were assessed. The primary endpoint was all-cause mortality within 30 days. The overall 30-day mortality rate was 15.8%. SAA levels at ED admission were markedly increased in nonsurvivors compared with those in survivors and demonstrated positive correlations with PSI score and other biomarkers. The area under the curve (AUC) value for SAA levels in predicting mortality was 0.768, which was higher than those for procalcitonin (AUC = 0.671) and high-sensitivity C-reactive protein (AUC = 0.657). The optimal cutoff value for SAA levels was determined to be 280.2 mg/L, yielding a sensitivity of 79.4% and a specificity of 68.5%. Multivariate analysis identified SAA level > 280.2 mg/L, PSI score > 125, intensive care unit admission, and presepsin level > 373 pg/mL as independent predictors of mortality. Thus, increased SAA levels at the time of ED presentation are independently associated with mortality in patients with CAP and may serve as a valuable prognostic biomarker to inform clinical decision-making.
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45442
Open AccessSerum amyloid A as a prognostic biomarker for 30-day mortality in patients with community-acquired pneumonia patients in the emergency department
Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality, particularly in older adults. Accurate risk assessment of patients with CAP in the emergency department (ED) is essential for guiding clinical decision-making. This study evaluated the prognostic value of serum amyloid A (SAA) levels for predicting 30-day mortality in patients with CAP presenting to the ED. The data of 398 adult patients with CAP who were admitted to the ED between November 2022 and March 2025 were retrospectively analyzed. Clinical parameters, laboratory biomarkers, and Pneumonia Severity Index (PSI) score were assessed. The primary endpoint was all-cause mortality within 30 days. The overall 30-day mortality rate was 15.8%. SAA levels at ED admission were markedly increased in nonsurvivors compared with those in survivors and demonstrated positive correlations with PSI score and other biomarkers. The area under the curve (AUC) value for SAA levels in predicting mortality was 0.768, which was higher than those for procalcitonin (AUC = 0.671) and high-sensitivity C-reactive protein (AUC = 0.657). The optimal cutoff value for SAA levels was determined to be 280.2 mg/L, yielding a sensitivity of 79.4% and a specificity of 68.5%. Multivariate analysis identified SAA level > 280.2 mg/L, PSI score > 125, intensive care unit admission, and presepsin level > 373 pg/mL as independent predictors of mortality. Thus, increased SAA levels at the time of ED presentation are independently associated with mortality in patients with CAP and may serve as a valuable prognostic biomarker to inform clinical decision-making.
- Open Access
- 13 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6835
Characteristics of Side Effects in Non-Emergency Indications Using Computer-Controlled Pressurized Monoplace Hyperbaric Chambers: A Retrospective Multicenter Study
Background: Hyperbaric oxygen therapy (HBOT) involves inhaling nearly 100% oxygen in a pressurized environment and is commonly used to treat various diseases and injuries. Despite its well-known safety, HBOT is associated with side effects, with frequent middle ear barotrauma (MEB) and oxygen toxicity. Understanding the characteristics and risk factors associated with these side effects is critical for improving patient compliance and treatment outcomes. Methods: This retrospective multicenter study aimed to analyze the characteristics and factors associated with side effects during HBOT using a computer-controlled pressurized monoplace hyperbaric chamber. We conducted a retrospective observational study across the two tertiary hospitals in Korea, involving patients who received HBOT from October 2016 for one hospital and October 2017 for another hospital to June 2020. Data were extracted from electronic medical records and hyperbaric chamber logs, including patient demographics, medical history, HBOT indications, and details of side effects. Statistical analyses, including chi-square and t-tests, were used to compare variables. Results: A total of 247 patients (mean age: 59.35 ± 15.05 years, 63.56% male) were included. The most common indications for HBOT were sudden sensorineural hearing loss (27.94%) and post-graft/flap (24.29%). Hypertension (46.15%) and diabetes mellitus (39.27%) were the most frequent comorbidities. Otalgia was the most prevalent side effect (33.20%), followed by chest discomfort (2.02%) and headache (1.62%). A significant proportion of patients (11.74%) terminated HBOT due to side effects, with most pauses occurring at pressures between 1.2 and 1.4 ATA (26.67%). Side effects, particularly otalgia, significantly impact patient compliance with HBOT. Conclusions: The incidence of side effects varies by pressure level during treatment, suggesting the need for tailored strategies to minimize side effects. This study highlights the importance of patient monitoring and education to improve the safety and efficacy of HBOT in monoplace chambers.
- 13 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6835
Open AccessCharacteristics of Side Effects in Non-Emergency Indications Using Computer-Controlled Pressurized Monoplace Hyperbaric Chambers: A Retrospective Multicenter Study
Background: Hyperbaric oxygen therapy (HBOT) involves inhaling nearly 100% oxygen in a pressurized environment and is commonly used to treat various diseases and injuries. Despite its well-known safety, HBOT is associated with side effects, with frequent middle ear barotrauma (MEB) and oxygen toxicity. Understanding the characteristics and risk factors associated with these side effects is critical for improving patient compliance and treatment outcomes. Methods: This retrospective multicenter study aimed to analyze the characteristics and factors associated with side effects during HBOT using a computer-controlled pressurized monoplace hyperbaric chamber. We conducted a retrospective observational study across the two tertiary hospitals in Korea, involving patients who received HBOT from October 2016 for one hospital and October 2017 for another hospital to June 2020. Data were extracted from electronic medical records and hyperbaric chamber logs, including patient demographics, medical history, HBOT indications, and details of side effects. Statistical analyses, including chi-square and t-tests, were used to compare variables. Results: A total of 247 patients (mean age: 59.35 ± 15.05 years, 63.56% male) were included. The most common indications for HBOT were sudden sensorineural hearing loss (27.94%) and post-graft/flap (24.29%). Hypertension (46.15%) and diabetes mellitus (39.27%) were the most frequent comorbidities. Otalgia was the most prevalent side effect (33.20%), followed by chest discomfort (2.02%) and headache (1.62%). A significant proportion of patients (11.74%) terminated HBOT due to side effects, with most pauses occurring at pressures between 1.2 and 1.4 ATA (26.67%). Side effects, particularly otalgia, significantly impact patient compliance with HBOT. Conclusions: The incidence of side effects varies by pressure level during treatment, suggesting the need for tailored strategies to minimize side effects. This study highlights the importance of patient monitoring and education to improve the safety and efficacy of HBOT in monoplace chambers.
- Open Access
- 16 October 2024
- Published by MDPI AG in Preprints.org
Analyzing the Characteristics of Complications Associated with Computer-controlled Pressurized Monoplace Hyperbaric Chambers: A Retrospective Observational Multicenter Study
Hyperbaric oxygen therapy (HBOT) involves inhaling nearly 100% oxygen in a pressurized environment and is commonly used to treat various diseases and injuries. Despite its well-known safety, HBOT is associated with complications, with frequent middle ear barotrauma (MEB) and oxygen toxicity. Understanding the characteristics and risk factors associated with these complications is critical for improving patient’s compliance and treatment outcomes. This retrospective multicenter study aimed to analyze the characteristics and factors associated with complications during HBOT using a computer-controlled pressurized monoplace hyperbaric chamber. We conducted a retrospective observational study across two tertiary hospitals in Korea, involving patients who received HBOT from October 2017 to June 2020. Data were extracted from electronic medical records and hyperbaric chamber logs, including patient demographics, medical history, HBOT indications, and details of complications. Statistical analyses, including chi-square and t-tests, were used to compare variables. A total of 247 patients (mean age: 59.35 ± 15.05 years, 63.56% male) were included. The most common indications for HBOT were sudden sensorineural hearing loss (27.94%) and post-graft/flap (24.29%). Hypertension (46.15%) and diabetes mellitus (39.27%) were the most frequent comorbidities. Otalgia was the most prevalent side effect (33.20%), followed by chest discomfort (2.02%) and headache (1.62%). A significant proportion of patients (11.74%) terminated HBOT due to complications, with most pauses occurring at pressures between 1.2 to 1.4 ATA (26.67%). Complications, particularly otalgia, significantly impact patient compliance with HBOT. The incidence of complications varies by pressure level during treatment, suggesting the need for tailored strategies to minimize complications. This study highlights the importance of patient monitoring and education to improve the safety and efficacy of HBOT in monoplace chambers.
- 16 October 2024
- Published by MDPI AG in Preprints.org
Open AccessAnalyzing the Characteristics of Complications Associated with Computer-controlled Pressurized Monoplace Hyperbaric Chambers: A Retrospective Observational Multicenter Study
Hyperbaric oxygen therapy (HBOT) involves inhaling nearly 100% oxygen in a pressurized environment and is commonly used to treat various diseases and injuries. Despite its well-known safety, HBOT is associated with complications, with frequent middle ear barotrauma (MEB) and oxygen toxicity. Understanding the characteristics and risk factors associated with these complications is critical for improving patient’s compliance and treatment outcomes. This retrospective multicenter study aimed to analyze the characteristics and factors associated with complications during HBOT using a computer-controlled pressurized monoplace hyperbaric chamber. We conducted a retrospective observational study across two tertiary hospitals in Korea, involving patients who received HBOT from October 2017 to June 2020. Data were extracted from electronic medical records and hyperbaric chamber logs, including patient demographics, medical history, HBOT indications, and details of complications. Statistical analyses, including chi-square and t-tests, were used to compare variables. A total of 247 patients (mean age: 59.35 ± 15.05 years, 63.56% male) were included. The most common indications for HBOT were sudden sensorineural hearing loss (27.94%) and post-graft/flap (24.29%). Hypertension (46.15%) and diabetes mellitus (39.27%) were the most frequent comorbidities. Otalgia was the most prevalent side effect (33.20%), followed by chest discomfort (2.02%) and headache (1.62%). A significant proportion of patients (11.74%) terminated HBOT due to complications, with most pauses occurring at pressures between 1.2 to 1.4 ATA (26.67%). Complications, particularly otalgia, significantly impact patient compliance with HBOT. The incidence of complications varies by pressure level during treatment, suggesting the need for tailored strategies to minimize complications. This study highlights the importance of patient monitoring and education to improve the safety and efficacy of HBOT in monoplace chambers.
- Open Access
- 3 January 2024
- Published by MDPI AG in Preprints.org
Safety Evaluation of Monoplace Hyperbaric Chamber and Clinical Characteristics of Hyperbaric Oxygen Therapy for Patients with Carbon Monoxide Poisoning
Hyperbaric oxygen therapy (HBOT) is a well-established treatment for carbon monoxide (CO) poisoning. HBOT is performed in a hyperbaric chamber, which increases the atmosphere absolute (ATA) and oxygen concentration in the chamber. To ensure patient safety during HBOT, a gas monitoring system is used to monitor the oxygen levels, ATA, and other parameters. This study aims to perform the safety evaluation of the monoplace hyperbaric chamber compared to a gas monitoring system in the treatment of CO poisoning. In addition, it examined the clinical characteristics of the patients diagnosed with CO poisoning who performed HBOT. In the safety evaluation of the monoplace chamber, it was compared the values of oxygen (O2), carbon dioxide (CO2), humidity, and temperature were measured in the hyperbaric chamber and gas monitoring system when operating at 2.0 ATA and 3.0 ATA. Moreover, in the clinical characteristics of patients with CO poisoning who performed HBOT, 1,006 patients were analyzed by using the data registry. Under the condition at 3.0 ATA, the average CO2 was higher in the hyperbaric chamber than in the gas monitoring system (p<0.001). Also, the average humidity was higher in the hyperbaric chamber than in the gas monitoring system (p=0.004). Under the condition at 2.0 ATA, the average humidity was higher in the hyperbaric chamber than in the gas monitoring system (p<0.001). Also, the average temperature was lower in the hyperbaric chamber than in the gas monitoring system (p<0.001). The mean age of the 1,006 CO poisoning patients who received HBOT was 44.93±19.78 years. According to the source of CO, 680 patients (67.6%) visited ER most commonly due to charcoal. The median maximal CO exposure time and time from rescue to ER were 4.0 hours and 3.09 hours, respectively. The median GCS score at the scene or ER was 15. According to the underlying comorbidities, psychiatric diseases (19.5%) were the most common, followed by hypertension (18.1%) and diabetes mellitus (11.5%). In the emergency room, some patients had appeared symptoms such as loss of consciousness (59.8%), shock (6.7%), or seizure (8.3%). The results of this study could be expected that HBOT can be effectively performed by monitoring the gas concentration change inside the hyperbaric chamber.
- 3 January 2024
- Published by MDPI AG in Preprints.org
Open AccessSafety Evaluation of Monoplace Hyperbaric Chamber and Clinical Characteristics of Hyperbaric Oxygen Therapy for Patients with Carbon Monoxide Poisoning
Hyperbaric oxygen therapy (HBOT) is a well-established treatment for carbon monoxide (CO) poisoning. HBOT is performed in a hyperbaric chamber, which increases the atmosphere absolute (ATA) and oxygen concentration in the chamber. To ensure patient safety during HBOT, a gas monitoring system is used to monitor the oxygen levels, ATA, and other parameters. This study aims to perform the safety evaluation of the monoplace hyperbaric chamber compared to a gas monitoring system in the treatment of CO poisoning. In addition, it examined the clinical characteristics of the patients diagnosed with CO poisoning who performed HBOT. In the safety evaluation of the monoplace chamber, it was compared the values of oxygen (O2), carbon dioxide (CO2), humidity, and temperature were measured in the hyperbaric chamber and gas monitoring system when operating at 2.0 ATA and 3.0 ATA. Moreover, in the clinical characteristics of patients with CO poisoning who performed HBOT, 1,006 patients were analyzed by using the data registry. Under the condition at 3.0 ATA, the average CO2 was higher in the hyperbaric chamber than in the gas monitoring system (p<0.001). Also, the average humidity was higher in the hyperbaric chamber than in the gas monitoring system (p=0.004). Under the condition at 2.0 ATA, the average humidity was higher in the hyperbaric chamber than in the gas monitoring system (p<0.001). Also, the average temperature was lower in the hyperbaric chamber than in the gas monitoring system (p<0.001). The mean age of the 1,006 CO poisoning patients who received HBOT was 44.93±19.78 years. According to the source of CO, 680 patients (67.6%) visited ER most commonly due to charcoal. The median maximal CO exposure time and time from rescue to ER were 4.0 hours and 3.09 hours, respectively. The median GCS score at the scene or ER was 15. According to the underlying comorbidities, psychiatric diseases (19.5%) were the most common, followed by hypertension (18.1%) and diabetes mellitus (11.5%). In the emergency room, some patients had appeared symptoms such as loss of consciousness (59.8%), shock (6.7%), or seizure (8.3%). The results of this study could be expected that HBOT can be effectively performed by monitoring the gas concentration change inside the hyperbaric chamber.
- Open Access
- 1 January 2023
- Published by MRE Press in Signa Vitae
- Vol. 19 (5) , 230-237
Impact of COVID-19 on suicidal attempts identified by face-to-face interviews
Epidemics of infectious diseases, such as the coronavirus disease 2019 (COVID-19) pandemic, have various psychiatric effects. These psychiatric problems are affected not only by the fear of infectious diseases, but also by economic and social changes following the epidemic. The aim of this study was to investigate the effect of COVID-19 pandemic on their suicide attempts through face-to-face interview records of suicide attempt patients who came to the emergency department (ED). This single-center, retrospective observational study was conducted with suicide attempt patients who visited ED from February 2020 to January 2021, who underwent a face-to-face interview with a psychiatrist. The patients were classified as a COVID-19 related group if they clearly mentioned a causal relationship between the COVID-19 pandemic and suicide attempts in the interview record, and a non-related group if they did not. A total of 502 patients were included, of which 90 were classified as a COVID-19 related group. As a result of comparing the demographic characteristics between the two groups, there were more patients who were employers by occupation and patients without a psychiatric history in the COVID-19 related group compared to the non-related group. There were various differences in motives for suicide attempt between the two groups, and unemployment, financial difficulty, and loneliness were statistically significantly higher in the COVID-19 related group than in the non-related group. The number of COVID-19 related groups increased toward the late period, but there was no statistically significant difference in suicide attempt motives. In conclusion, the COVID-19 pandemic has had a variety of effects on suicide attempt patients and also affects suicide attempts in patients with no psychiatric history. As motives for suicide attempts by the COVID-19 related group, unemployment, financial difficulty, and loneliness showed statistically significant results.
- 1 January 2023
- Published by MRE Press in Signa Vitae
- Vol. 19 (5) , 230-237
Open AccessImpact of COVID-19 on suicidal attempts identified by face-to-face interviews
Epidemics of infectious diseases, such as the coronavirus disease 2019 (COVID-19) pandemic, have various psychiatric effects. These psychiatric problems are affected not only by the fear of infectious diseases, but also by economic and social changes following the epidemic. The aim of this study was to investigate the effect of COVID-19 pandemic on their suicide attempts through face-to-face interview records of suicide attempt patients who came to the emergency department (ED). This single-center, retrospective observational study was conducted with suicide attempt patients who visited ED from February 2020 to January 2021, who underwent a face-to-face interview with a psychiatrist. The patients were classified as a COVID-19 related group if they clearly mentioned a causal relationship between the COVID-19 pandemic and suicide attempts in the interview record, and a non-related group if they did not. A total of 502 patients were included, of which 90 were classified as a COVID-19 related group. As a result of comparing the demographic characteristics between the two groups, there were more patients who were employers by occupation and patients without a psychiatric history in the COVID-19 related group compared to the non-related group. There were various differences in motives for suicide attempt between the two groups, and unemployment, financial difficulty, and loneliness were statistically significantly higher in the COVID-19 related group than in the non-related group. The number of COVID-19 related groups increased toward the late period, but there was no statistically significant difference in suicide attempt motives. In conclusion, the COVID-19 pandemic has had a variety of effects on suicide attempt patients and also affects suicide attempts in patients with no psychiatric history. As motives for suicide attempts by the COVID-19 related group, unemployment, financial difficulty, and loneliness showed statistically significant results.
- Open Access
Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department
Background and Objectives: Presepsin (PSS) is an independent predictor for estimating disease severity and prognosis in septic patients. Few studies have reported the associations between plasma PSS and the severity and prognosis in patients with community-acquired pneumonia (CAP). We investigated whether a high plasma PSS level was associated with 30-day mortality in CAP patients. Materials and Methods: This retrospective single-center study was conducted in an emergency department. The PSS level was measured in 211 adult CAP patients admitted to the hospital and followed for up to 30 days. We recorded the pneumonia severity index (PSI) and the CURB-65 score. The primary outcome was death from any cause within 30 days. Results: The plasma PSS levels were significantly elevated in the high-risk group (PSI > 130) compared with the low- (PSI < 91) or moderate-risk groups (PSI 91–130). Forty-four patients (20.9%) died within 30 days of admission. Non-survivors had significantly higher plasma PSS levels than survivors among CAP patients: 1083 (697–1736) pg/mL vs. 385 (245–554) pg/mL (p < 0.001). The area under the curve (AUC) to predict 30-day mortality was highest for PSS (0.867), followed by procalcitonin (0.728) and lactate (0.616). The cutoff level of plasma PSS for 30-day mortality was >754 pg/mL. The combination of PSI and plasma PSS level improved the predictive ability for 30-day mortality (AUC = 0.892). Cox regression analysis showed that higher PSS levels (>754 pg/mL) and higher PSI (>126) were associated with 30-day mortality in CAP patients (hazard ratios of 19.472 and 6.375, respectively). Conclusion: Elevated plasma PSS is associated with severity and 30-day mortality in hospitalized CAP patients. Combining plasma PSS level and PSI could significantly improve the predictive ability of PSS for 30-day mortality.
Open AccessPrognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department
Background and Objectives: Presepsin (PSS) is an independent predictor for estimating disease severity and prognosis in septic patients. Few studies have reported the associations between plasma PSS and the severity and prognosis in patients with community-acquired pneumonia (CAP). We investigated whether a high plasma PSS level was associated with 30-day mortality in CAP patients. Materials and Methods: This retrospective single-center study was conducted in an emergency department. The PSS level was measured in 211 adult CAP patients admitted to the hospital and followed for up to 30 days. We recorded the pneumonia severity index (PSI) and the CURB-65 score. The primary outcome was death from any cause within 30 days. Results: The plasma PSS levels were significantly elevated in the high-risk group (PSI > 130) compared with the low- (PSI < 91) or moderate-risk groups (PSI 91–130). Forty-four patients (20.9%) died within 30 days of admission. Non-survivors had significantly higher plasma PSS levels than survivors among CAP patients: 1083 (697–1736) pg/mL vs. 385 (245–554) pg/mL (p < 0.001). The area under the curve (AUC) to predict 30-day mortality was highest for PSS (0.867), followed by procalcitonin (0.728) and lactate (0.616). The cutoff level of plasma PSS for 30-day mortality was >754 pg/mL. The combination of PSI and plasma PSS level improved the predictive ability for 30-day mortality (AUC = 0.892). Cox regression analysis showed that higher PSS levels (>754 pg/mL) and higher PSI (>126) were associated with 30-day mortality in CAP patients (hazard ratios of 19.472 and 6.375, respectively). Conclusion: Elevated plasma PSS is associated with severity and 30-day mortality in hospitalized CAP patients. Combining plasma PSS level and PSI could significantly improve the predictive ability of PSS for 30-day mortality.
- Open Access
- 15 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (28) , e29919
Plasma presepsin level predicts acute kidney injury in patients with sepsis in the emergency department
Acute kidney injury (AKI) is a common complication in patients with sepsis. We evaluated the potential prognostic value of plasma presepsin to predict AKI in patients with sepsis in the emergency department. A total of 193 patients diagnosed with sepsis based on the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) were included in this observational study. AKI was defined according to the Kidney Disease Improving Global Outcomes clinical practice guideline. Plasma presepsin levels were measured on admission to the emergency department. We compared plasma presepsin levels between patients who did and those who did not develop AKI. AKI occurred in 100 (51.8%) patients. The median plasma presepsin level was significantly higher in patients with AKI than in those without AKI (1061 pg/mL vs 495 pg/mL, P <.001). Plasma presepsin levels were significantly increased in patients with AKI stage 3 compared with those with AKI stages 1 and 2 (P =.001). The area under the curve of presepsin for predicting AKI was 0.793 (95% confidence interval: 0.729–0.848). The optimal presepsin cutoff value for predicting AKI was >572 pg/mL, with a sensitivity of 77.0% and specificity of 81.7%. Plasma presepsin level is a valuable biomarker for the prediction of AKI in patients with sepsis in the emergency department.
- 15 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (28) , e29919
Open AccessPlasma presepsin level predicts acute kidney injury in patients with sepsis in the emergency department
Acute kidney injury (AKI) is a common complication in patients with sepsis. We evaluated the potential prognostic value of plasma presepsin to predict AKI in patients with sepsis in the emergency department. A total of 193 patients diagnosed with sepsis based on the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) were included in this observational study. AKI was defined according to the Kidney Disease Improving Global Outcomes clinical practice guideline. Plasma presepsin levels were measured on admission to the emergency department. We compared plasma presepsin levels between patients who did and those who did not develop AKI. AKI occurred in 100 (51.8%) patients. The median plasma presepsin level was significantly higher in patients with AKI than in those without AKI (1061 pg/mL vs 495 pg/mL, P <.001). Plasma presepsin levels were significantly increased in patients with AKI stage 3 compared with those with AKI stages 1 and 2 (P =.001). The area under the curve of presepsin for predicting AKI was 0.793 (95% confidence interval: 0.729–0.848). The optimal presepsin cutoff value for predicting AKI was >572 pg/mL, with a sensitivity of 77.0% and specificity of 81.7%. Plasma presepsin level is a valuable biomarker for the prediction of AKI in patients with sepsis in the emergency department.
- Open Access
- 7 December 2021
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 8 (4) , 251-254
Should steroids be used for anaphylaxis after the COVID-19 vaccine?
- 7 December 2021
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 8 (4) , 251-254
Open AccessShould steroids be used for anaphylaxis after the COVID-19 vaccine?
- Open Access
- 13 September 2021
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 8 (3) , 153-159
Adverse events and preventive measures related to COVID-19 vaccines
The coronavirus disease 2019 (COVID-19) vaccines are categorized according to the manufacturing technique, including mRNA vaccines and adenovirus vector vaccines. According to previous studies, the reported efficacy of the COVID-19 vaccine is excellent regardless of the type of vaccine, and the majority of studies have shown similar results for safety. Most of the adverse reactions after vaccination were mild or moderate grade, and severe reactions were reported in a very small proportion. However, the adverse reactions that might occur after nationwide vaccinations can contribute to crowding of emergency departments, and this can further lead to significant obstacles to providing necessary treatment for life-threatening conditions. Therefore, as emergency physicians, we would like to present some concerns and suggestions to prevent these predictable problems.
- 13 September 2021
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 8 (3) , 153-159
Open AccessAdverse events and preventive measures related to COVID-19 vaccines
The coronavirus disease 2019 (COVID-19) vaccines are categorized according to the manufacturing technique, including mRNA vaccines and adenovirus vector vaccines. According to previous studies, the reported efficacy of the COVID-19 vaccine is excellent regardless of the type of vaccine, and the majority of studies have shown similar results for safety. Most of the adverse reactions after vaccination were mild or moderate grade, and severe reactions were reported in a very small proportion. However, the adverse reactions that might occur after nationwide vaccinations can contribute to crowding of emergency departments, and this can further lead to significant obstacles to providing necessary treatment for life-threatening conditions. Therefore, as emergency physicians, we would like to present some concerns and suggestions to prevent these predictable problems.
- Open Access
- 13 August 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (32) , e26847
Comparison of emergency department utilization trends between the COVID-19 pandemic and control period
Infectious disease pandemics has a great impact on the use of medical facilities. The purpose of this study was to analyze the effects of coronavirus disease 2019 (COVID-19) on the use of emergency medical facilities in the Republic of Korea. This single-center, retrospective observational study was conducted in a tertiary teaching hospital located in Incheon Metropolitan City, Republic of Korea. We set the pandemic period as February 19, 2020 to April 18, 2020, and the control period was set to the same period in 2018 and 2019. All consecutive patients who visited the emergency department (ED) during the study period were included. Patients were divided into 3 groups according to age (pediatric patients, younger adult patients and older adult patients). The total number, demographics, clinical data, and diagnostic codes of ED patients were analyzed. The total number of ED patients in the pandemic period was lower than that in the control period, which was particularly pronounced for pediatric patients. The proportion of patients who used the 119 ambulances increased in all 3 groups (P = .002, P < .001, and P = .001), whereas the proportion of patients who visited on foot was decreased (P = .006, P < .001, and P = .027). In terms of diagnostic codes, a significant decrease was observed in the proportion of certain infectious or parasitic diseases (A00-B99), and respiratory diseases (J00-J99) in the pediatric and younger adult patient groups (P < .001 and P < .001, respectively). The COVID-19 pandemic reduced the number of ED patients; however, the proportion of patients using ambulances increased. In particular, the proportion of patients with diagnostic codes for infectious and respiratory diseases significantly decreased during the pandemic period.
- 13 August 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (32) , e26847
Open AccessComparison of emergency department utilization trends between the COVID-19 pandemic and control period
Infectious disease pandemics has a great impact on the use of medical facilities. The purpose of this study was to analyze the effects of coronavirus disease 2019 (COVID-19) on the use of emergency medical facilities in the Republic of Korea. This single-center, retrospective observational study was conducted in a tertiary teaching hospital located in Incheon Metropolitan City, Republic of Korea. We set the pandemic period as February 19, 2020 to April 18, 2020, and the control period was set to the same period in 2018 and 2019. All consecutive patients who visited the emergency department (ED) during the study period were included. Patients were divided into 3 groups according to age (pediatric patients, younger adult patients and older adult patients). The total number, demographics, clinical data, and diagnostic codes of ED patients were analyzed. The total number of ED patients in the pandemic period was lower than that in the control period, which was particularly pronounced for pediatric patients. The proportion of patients who used the 119 ambulances increased in all 3 groups (P = .002, P < .001, and P = .001), whereas the proportion of patients who visited on foot was decreased (P = .006, P < .001, and P = .027). In terms of diagnostic codes, a significant decrease was observed in the proportion of certain infectious or parasitic diseases (A00-B99), and respiratory diseases (J00-J99) in the pediatric and younger adult patient groups (P < .001 and P < .001, respectively). The COVID-19 pandemic reduced the number of ED patients; however, the proportion of patients using ambulances increased. In particular, the proportion of patients with diagnostic codes for infectious and respiratory diseases significantly decreased during the pandemic period.